Δοκιμάστε άλλη αναζήτηση
Όνομα | Ηλικία | Από | Τίτλος |
---|---|---|---|
Sharon G. Adler | - | - | Member of Scientific Advisory Board |
Stephen C. Glover | 63 | 2022 | Co-Founder, Chairman, CEO & President |
Pablo A. Guzman | 73 | 2023 | Chief Medical Officer, Senior VP of Medical Affairs & Chairman of Renal Scientific Advisory Board |
Min-Chul Park | 41 | 2022 | Independent Director |
Robert W. Keane | - | - | Member of Scientific Advisory Board |
Douglas H. Farrar | 58 | - | Member of Scientific Advisory Board |
Alan C. Herman | 75 | - | Member of Scientific Advisory Board |
William F. Bennett | 74 | - | Member of Scientific Advisory Board |
Robert G. Finizio | 52 | 2022 | Independent Director |
Miguel S. Barbosa | 65 | - | Member of Scientific Advisory Board |
Marlene Haffner | 82 | - | Member of Scientific Advisory Board |
Fernando C. Fervenza | - | - | Member of Renal Scientific Advisory Board |
W. Dalton Dietrich | 70 | - | Member of Scientific Advisory Board |
Daniel G. Baker | - | - | Member of Scientific Advisory Board |
James R. Sapirstein | 62 | 2023 | Independent Director |
Gregory G. Freitag | 61 | 2023 | Independent Director |
Nicholas A. LaBella | 67 | 2022 | Member of Scientific Advisory Board |
Juan Pablo de Rivero Vaccari | - | - | Member of Scientific Advisory Board |
Alessia Fornoni | - | - | Member of Scientific Advisory Board |
Helen Bramlett | - | - | Member of Scientific Advisory Board |
Daniel C. Cattran | - | - | Member of Renal Scientific Advisory Board |
Richard J. Glassock | - | 2023 | Member of Renal Scientific Advisory Board |
Douglas T. Golenbock | - | 2023 | Member of Scientific Advisory Board |
Είστε σίγουροι πώς θέλετε να μπλοκάρετε τον/την %USER_NAME%;
Με αυτή την ενέργεια, εσείς και ο/η %USER_NAME% δεν θα μπορείτε να δείτε ο ένας τις αναρτήσεις του άλλου στο Investing.com.
Ο/Η %USER_NAME% προστέθηκε επιτυχώς στη λίστα μπλοκαρίσματός σας
Επειδή έχετε μόλις ξεμπλοκάρει αυτό το άτομο θα πρέπει να περιμένετε 48 ώρες πριν μπορέσετε να τον ξαναμπλοκάρετε.
Πείτε μας τη γνώμη σας γι' αυτό το σχόλιο
Σας Ευχαριστούμε!
Η αναφορά σας στάλθηκε στους επόπτες για επιθεώρηση